Related Experiment Video

Updated: Aug 14, 2026

Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes
12:12

Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes

Published on: June 16, 2011

Transforming growth factor-beta and natural killer T-cells are involved in the protective effect of a bacterial

Marie-Alexandra Alyanakian1, Françoise Grela, Aude Aumeunier

  • 1INSERM U580, Hôpital Necker-Enfants Malades, 161 Rue de Sèvres, 75015 Paris, France.

Diabetes
|December 29, 2005
PubMed

Insights

Oral administration of a bacterial extract (OM-85) delays type 1 diabetes in NOD mice. This therapeutic effect depends on transforming growth factor-beta (TGF-β) and natural killer T-cells, not T-helper type 2 cytokines.

Area of Science:

  • Immunology
  • Microbiology
  • Endocrinology

Background:

  • Type 1 diabetes (T1D) is an autoimmune disease.
  • NOD mice are a common model for T1D research.
  • Bacterial extracts are being investigated for immunomodulatory effects.

Purpose of the Study:

  • To investigate the therapeutic potential of OM-85 in preventing T1D onset in NOD mice.
  • To elucidate the immunological mechanisms underlying OM-85's protective effects.

Main Methods:

  • Administration of OM-85 orally and intraperitoneally to NOD mice at different ages.
  • Use of genetically deficient mice (CD1d-/-) and cytokine-neutralizing antibodies.
  • Assessment of T-helper type 2 cytokines (IL-4, IL-10) and transforming growth factor-beta (TGF-β).
  • Evaluation of the role of natural killer T-cells.
  • Stimulation of dendritic cells and splenocyte cytokine production via Toll-like receptors (TLRs).

Main Results:

  • Oral OM-85 delayed T1D onset, while intraperitoneal administration completely prevented it.
  • Optimal protection was achieved when treatment began at 3 or 6 weeks of age.
  • The therapeutic effect was dependent on TGF-β and involved natural killer T-cells.
  • T-helper type 2 cytokines (IL-4, IL-10) were not involved in the protective mechanism.
  • OM-85 stimulated dendritic cells and induced TGF-β production in a TLR-2, TLR-4, and MyD88-dependent manner, excluding lipopolysaccharide.

Conclusions:

  • OM-85 demonstrates significant potential in preventing T1D in a preclinical model.
  • The mechanism involves TGF-β signaling and natural killer T-cell activity.
  • Further research is needed to identify specific OM-85 components responsible for T1D protection.

More Related Videos

A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro10:36

A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro

Published on: January 9, 2018

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...